技術指標
指標
數值
方向
MACD(12,26,9)
-0.072
賣出
RSI(14)
36.241
中性
STOCH(KDJ)(9,3,3)
21.648
中性
ATR(14)
0.100
高波動
CCI(14)
-97.322
中性
Williams %R
89.016
超賣
TRIX(12,20)
-1.306
賣出
StochRSI(14)
49.259
中性
搜尋
ABVC Biopharma Inc
ABVC添加自選
1.010USD
-0.070-6.48%
收盤 07-31 16:00（美東）報價延遲15分鐘
26.03M總市值
虧損本益比TTM
關鍵數據
1.080今開
1.080最高
25.44K成交量
虧損本益比TTM
--本益比動
--股利TTM
0.10%換手率
1.080昨收
1.010最低
23.31K成交額
虧損本益比靜
2.42市淨率
0.00%股息率 TTM
-52.72%ROA
5.48052週最高
0.34量比
-4.90M淨利潤
25.77M總股本
-0.3983每股盈餘TTM
0.54Beta
-106.65%ROE
0.88052週最低
6.48%振幅
100.00%毛利率
26.03M總市值
-8.15回報/風險
5.29%風險率
TradingKey ABVC Biopharma Inc股票評分
單位: USD 更新時間: 2026-07-31操作建議
ABVC Biopharma Inc當前公司基本面數據相對穩定，增長潛力很大。當前估值合理，在生物技術與醫療研究行業排名178/385位。機構持股佔比非常高，中期看，股價處於平穩狀態。近一個月，市場表現非常差，但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間，可以做區間波段操作。
ABVC Biopharma Inc評分
壓力支撐
由於公司未披露，未能獲取相關數據
多維評測
本期評分
上期評分
公司輿情
過去24小時
熱度
過冷
過熱
看好
ABVC Biopharma Inc亮點
亮點風險
ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on developing products and technologies to combat various diseases. Its pipeline includes ABV-1504, ABV-1505, ABV-1601, ABV-1702, ABV-1703, ABV- 1501, ABV-1519 and ABV-1701. The Company is developing and researching ABV-1504, a botanical reuptake inhibitor that targets norepinephrine to treat Major Depressive Disorder (MDD). ABV-1505 to treat attention deficit hyperactivity disorder (ADHD). It has developed ABV-1601 for treating depression in cancer patients. ABV-1702 to treat Myelodysplastic syndromes. It has developed an indication for pancreatic cancer from maitake extract, named ABV-1703. ABV-1501 for the treatment of Triple Negative Breast Cancer. ABV-1701 Vitargus for the treatment of Retinal Detachment or Vitreous Hemorrhage. ABV-1519 for the treatment of Non-Small Cell Lung Cancer. It also focuses on the development of new drugs and medical devices derived from plants.
分析師目標
基於
0
分析師
--
評級
0.000
目標均價
0.00%
漲幅空間
ABVC Biopharma Inc新聞
即將為您帶來更多新聞，敬請期待。 。 。
技術指標
移動平均線
指標
數值
方向
MA5
1.036
賣出
MA10
1.114
賣出
MA20
1.323
賣出
MA50
1.347
賣出
MA100
1.265
賣出
MA200
1.759
賣出
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
ABVC Biopharma Inc簡介
ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on developing products and technologies to combat various diseases. Its pipeline includes ABV-1504, ABV-1505, ABV-1601, ABV-1702, ABV-1703, ABV- 1501, ABV-1519 and ABV-1701. The Company is developing and researching ABV-1504, a botanical reuptake inhibitor that targets norepinephrine to treat Major Depressive Disorder (MDD). ABV-1505 to treat attention deficit hyperactivity disorder (ADHD). It has developed ABV-1601 for treating depression in cancer patients. ABV-1702 to treat Myelodysplastic syndromes. It has developed an indication for pancreatic cancer from maitake extract, named ABV-1703. ABV-1501 for the treatment of Triple Negative Breast Cancer. ABV-1701 Vitargus for the treatment of Retinal Detachment or Vitreous Hemorrhage. ABV-1519 for the treatment of Non-Small Cell Lung Cancer. It also focuses on the development of new drugs and medical devices derived from plants.
公司代碼ABVC
公司ABVC Biopharma Inc
CEOPatil (Uttam Yashwant)
網址https://abvcpharma.com/
公司股東
相關品種
-0.53%
+0.27%
-0.92%
-2.51%
+0.32%
-1.45%
-0.64%
-0.82%
-8.79%
+0.52%
+0.68%
-0.95%
-0.71%
+0.44%
-1.08%
+3.29%
0.00%
+1.30%
-0.90%
-2.15%熱門品種
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4041.430
-61.400 (-1.50%)
常見問題
ABVC Biopharma Inc(ABVC)的當前股價是多少？
ABVC Biopharma Inc(ABVC)的當前股價是 1.02。
ABVC Biopharma Inc 的股票代碼是什麼？
ABVC Biopharma Inc的股票代碼是ABVC。
ABVC Biopharma Inc股票的52週最高點是多少？
ABVC Biopharma Inc股票的52週最高點是5.48。
ABVC Biopharma Inc股票的52週最低點是多少？
ABVC Biopharma Inc股票的52週最低點是0.88。
ABVC Biopharma Inc的市值是多少？
ABVC Biopharma Inc的市值是26.26M。
ABVC Biopharma Inc(ABVC)股票的每股收益（EPS TTM）是多少
ABVC Biopharma Inc(ABVC)股票的每股收益（EPS TTM）是-0.39。